DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Oral angiogenesis
Angiokinase inhibitors
Angiokinase inhibitors are a new therapeutic target for the management of cancer. They inhibit tumour angiogenesis, one of the key processes leading to invasion and metastasis of solid tumours, by targeting receptor tyrosine kinases. Examples include intedanib (BIBF 1120), afatinib (BIBW 2992) and motesanib (AMG 706).
Oral angiogenesis - List of case studies
- Treatments
-
Androgen block Androgen suppression Angiogenesis inhibitors Angiographic exclusion of lesion Angioplasty ... therapy Anticholinergis Anticoagulant oral therapy Anticoagulant therapy Anticoagulant treatment ... Hypocholesterolemizing therapy Hypoglycemizing oral drug Hyposodic diet Hysterectomy ...
- Papillary Carcinoma of Thyroid with Multiple and Diffuse Nodular Secondarisms of the Pulmonary Parenchyma
-
complete blood count in 1 week. Other treatment: Oral Antidiabetic medications Use of a pessary ... presented that demonstrate activity in PTC with oral angiogenesis/multikinase inhibitors , such as AMG 706 (Sherman, NEJM, ...
- Drugs
-
Hypocholesterolemizing drug Hypoglycemizing oral drug I IGF1 IL-2 fusion proteins IMID INSULIN ... Oral Antidiabetic medications Oral Warfarin Oral angiogenesis Oral corticosteroids Oral cyclophosphamide Oral ...
- IgG Multiple Myeloma
-
intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma. Br J Haematol 2007; ... with improvement of abnormal bone metabolism and angiogenesis. Leukemia 2008; 22:2247. 9. Popat, R, Oakervee, H, Williams, ...